Correlation Between Cardinal Health and Novo Nordisk

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cardinal Health and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardinal Health and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardinal Health and Novo Nordisk AS, you can compare the effects of market volatilities on Cardinal Health and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardinal Health with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardinal Health and Novo Nordisk.

Diversification Opportunities for Cardinal Health and Novo Nordisk

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Cardinal and Novo is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Cardinal Health and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Cardinal Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardinal Health are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Cardinal Health i.e., Cardinal Health and Novo Nordisk go up and down completely randomly.

Pair Corralation between Cardinal Health and Novo Nordisk

Considering the 90-day investment horizon Cardinal Health is expected to under-perform the Novo Nordisk. But the stock apears to be less risky and, when comparing its historical volatility, Cardinal Health is 1.28 times less risky than Novo Nordisk. The stock trades about -0.21 of its potential returns per unit of risk. The Novo Nordisk AS is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  10,691  in Novo Nordisk AS on September 14, 2024 and sell it today you would earn a total of  170.00  from holding Novo Nordisk AS or generate 1.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Cardinal Health  vs.  Novo Nordisk AS

 Performance 
       Timeline  
Cardinal Health 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Cardinal Health are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Cardinal Health is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
Novo Nordisk AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novo Nordisk AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Cardinal Health and Novo Nordisk Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cardinal Health and Novo Nordisk

The main advantage of trading using opposite Cardinal Health and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardinal Health position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.
The idea behind Cardinal Health and Novo Nordisk AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Bonds Directory
Find actively traded corporate debentures issued by US companies
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes